Skip to content
OpenCapital
Get started

ANI Pharmaceuticals ANIP EBITDA

EBITDA at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$34.51M-26.0%
ALN
Alnylam PharmaceuticalsALNY
$282.19M+769%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$46.24M+73.2%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$116.05M-23.8%
Viatris logo
ViatrisVTRS
——
Amgen logo
AmgenAMGN
——

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
CapEx$6.1M+146%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.89B+18.3%
Enterprise value$1.88B+5.8%
P/E20.5×—
P/S2×-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%—
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Calculated from ANI Pharmaceuticals’s reported figures.

$38.9Mebit+
$20.9MDepreciation Depletion & Amortization
=$59.81M

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's EBITDA?
ANI Pharmaceuticals (ANIP) reported EBITDA of $59.81M in Q1 2026.
How has ANI Pharmaceuticals's EBITDA changed year-over-year?
ANI Pharmaceuticals's EBITDA increased by 21.8% year-over-year, from $49.09M to $59.81M.
What is the long-term trend for ANI Pharmaceuticals's EBITDA?
Over 4 years (2021 to 2025), ANI Pharmaceuticals's EBITDA has grown at a 128.3% compound annual growth rate (CAGR), from $7.46M to $202.51M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.